Introduction
============

Disorders of the cerebral circulation are a prominent cause of mortality and morbidity in newborns and can result in lifelong disabilities (Du Plessis and Volpe [@b5]; Shankaran and Laptook [@b20]; Dehaes et al. [@b4]). The neonatal brain is more susceptible to injury from fluctuations in blood flow than the adult brain because of rapid development and proliferation of new neurons and vessels (Calvert and Zhang [@b2]). A better understanding of cerebrovascular control mechanisms is thus vital to neonatal medicine.

There is no question that regulatory mechanisms of cerebral control are not the same as those in the adult (Leffler [@b10]; Fermandez‐Lopez et al. [@b6]). To understand the physiology and pathophysiology, we must study newborns. Newborn pigs are an outstanding species to use because of virtually identical cardiovascular system, rapid maturation, and size that allows many techniques impossible in a newborn rodent. For example, cerebral circulatory prostacyclin dominance switches over to NO over weeks to months (Willis and Leffler [@b22]).

In the cerebral vasculature, arterial and arteriolar partial pressure of CO~2~ (Paco~2~) is a primary regulatory stimulus controlling blood flow (Busija and Heistad [@b1]). The mechanisms involved in cerebrovascular tone regulation by Paco~2~ in the newborn are of clinical significance, in part, because current clinical practice in mechanical ventilation of preterm newborns is to permit higher Paco~2~ by using lower ventilator pressures with the goal of preventing lung injury (Calvert and Zhang [@b2]; Croinin et al. [@b3]; Kavanagh and Laffey [@b9]). The resulting elevation of Paco~2~ above normal dilates cerebral arterioles.

ATP‐sensitive potassium (K~ATP~) channels have been shown to be present in the cerebral vasculature of some animal species (Busija and Heistad [@b1]; Masuzawa et al. [@b16]). In adult rat systemic arteries, K~ATP~ channel activation appears to be involved in dilation caused by hypercapnia (Masuzawa et al. [@b16]; Wang et al. [@b21]; Zhuo et al. [@b23]). Also, in a recent publication, we showed K~ATP~ channel activation as a mechanism for H~2~S‐induced dilation in newborn piglet cerebral arterioles (Leffler et al. [@b12]). This is relevant because inhibition of H~2~S production decreased pial arteriolar dilation to hypercapnia. These combined findings suggest there may be a role of K~ATP~ channels in hypercapnia‐induced cerebrovascular dilation in newborns.

However, the participation of K~ATP~ channels in the neonatal cerebrovascular response to hypercapnia remains uncertain (Leffler et al. [@b11]).

Therefore, the present study was initially designed to address the hypothesis that K~ATP~ channels play a role in neonatal cerebral arteriolar vasodilation in response to hypercapnia.

Methods
=======

All procedures involving animals have been reviewed and approved by the Animal Care and Use Committee of the University of Tennessee Health Science Center. Newborn pigs (within the first 7 days of life) weighing 1.5--3 kg were anesthetized with ketamine hydrochloride (33 mg/kg, i.m.) and acepromazine (3.3 mg/kg, i.m.) or ketamine hydrochloride (15 mg/kg, i.m.) and xylazine (2 mg/kg, i.m.). We have been unable to detect any effect of the preanesthetic on subsequent cerebrovascular responses to any vasogenic stimulus tested. Anesthesia was maintained by *α*‐chloralose (50 mg/kg, i.v.).

The piglets were intubated via tracheostomies and placed on mechanical ventilation. Femoral veins were cannulated for anesthetic injection and femoral arteries were cannulated for continuous blood pressure monitoring and arterial blood sampling for blood gas and pH measurements. Blood pressure, blood gases, pH, and body temperature were maintained within normal range except during hypercapnia treatment.

Cranial window implantation
---------------------------

The scalp of each piglet was incised and retracted, and an opening of 2 cm in diameter created through the skull over the parietal cortex. The dura mater was cut and then placed over the cut bone edges. A stainless steel frame with a glass pane was placed in the hole, sealed with bone wax, and fixed with dental acrylic. The cranial window frame had side needle ports through which artificial cerebrospinal fluid (aCSF) was placed under the window. The aCSF was equilibrated with 6% CO~2~‐ and 6% O~2~‐producing gases and pH within normal range for CSF (pH = 7.35--7.40) and both Po~2~ and Pco~2~ between 42 and 46 mmHg. Pial vessels were observed through the window with a dissecting microscope. Arteriole diameters were measured using a video micrometer coupled to a television camera mounted on the microscope and a video monitor.

Pharmacological agents used
---------------------------

All pharmacological agents were applied topically in the aCSF under the window. Pinacidil (10^−5^ mol/L) was used as the most selective activator of K~ATP~ channels. NS1619 (2 × 10^−6^ mol/L), a K~Ca~ channel agonist, was used as a control that dilates cerebral arterioles by a K~ATP~ channel‐independent mechanism. Similarly, sodium nitroprusside (SNP) (10^−6^ mol/L) and isoproterenol (10^−6^ mol/L) were used as endothelium‐independent, cGMP‐ and cAMP‐dependent vasodilators, respectively. Dilations to pinacidil, NS1619, SNP, and/or isoproterenol were measured before and in the presence of the potent and selective K~ATP~ channel antagonist glibenclamide (10^−7^ or 10^−6^ mol/L) as described in the text. Artificial CSF without or with glibenclamide, as appropriate, was used to flush the windows (as controls) between experimental treatments and allowing the pial arteriolar diameter to return to baseline.

Dilation to hypercapnia
-----------------------

Hypercapnia was caused by ventilation with 5% or 10% CO~2~, 21% O~2~, and the balance N~2~. These mixtures increased the Paco~2~ to approximately 50 and 75 mmHg, respectively, from the baseline Paco~2~ of 30--40 mmHg. As described in Results, in some piglets, we measured dilation to hypercapnia before and then in the presence of glibenclamide to determine if K~ATP~ channel blockade can prevent dilation to hypercapnia. In others, glibenclamide was placed under the cranial window at 5 min of hypercapnia and pial arteriolar diameters were recorded at 5, 10, and 15 min after glibenclamide during hypercapnia to see if inhibition of K~ATP~ channels can reverse dilation to hypercapnia.

The other pharmacological agents described above were used to confirm efficacy and selectivity of glibenclamide or paxillin as an inhibitor of K~ATP~ channels and K~Ca~ channels, respectively.

Glibenclamide was stored in ethanol (10^−3^ mol/L, −20°C) or dissolved freshly in DMSO and diluted with aCSF to 10^−7^ or 10^−6^ mol/L for injection under the cranial window. The blockade of dilation to pinacidil (10^−5^ mol/L) by glibenclamide confirmed the K~ATP~ channels were blocked and no change to isoproterenol (10^−6^ mol/L), SNP (10^−5^ mol/L), or NS1619 (10^−6^ mol/L) confirmed inhibition is selective for K~ATP~ channels. Time‐vehicle controls (repeat without glibenclamide or paxillin) were done randomly with the protocols without apparent or significant differences. Protocols for paxillin were the same with the anticipated and produced result of inhibition of dilation to paxillin being NS1619 rather than pinacidil.

Statistical analysis
--------------------

Data are presented as means ± SEM. Comparison among populations within each experimental group used ANOVA with or without repeated measures depending on experimental design, followed by Tukey post hoc test to determine differences between groups. *P* \< 0.05 was considered significant.

Results
=======

Dilation of newborn pial arterioles to hypercapnia may be dependent, in part, to the size of the vessels measured. Therefore, we divided the control arterioles into three groups: large arterioles (\>80 *μ*m), medium arterioles (55--80 *μ*m), and small arterioles (less than 55 *μ*m) (Fig. [1](#fig01){ref-type="fig"}). In this report, the average and median arteriole had a diameter of \~70 *μ*m. As expected, pial arterioles of all sizes dose‐dependently dilated in response to hypercapnia. The dilations increased progressively as the size of the arteriole decreased between 80 and 40 *μ*m. Topical application of pinacidil (10^−5^ mol/L), a K~ATP~ channel activator, caused pial arteriolar dilation in newborn pigs (Fig. [2](#fig02){ref-type="fig"}). This dilation was blocked by glibenclamide placed under the cranial window, demonstrating efficacy of K~ATP~ channel inhibition. In contrast, glibenclamide alone had no effect on newborn piglet pial arteriolar diameters (PAD) (Fig. [2](#fig02){ref-type="fig"}). Also, dilation to NS1619, a K~Ca~ channel activator, was not inhibited by glibenclamide (Fig. [2](#fig02){ref-type="fig"}). Dilation to sodium nitroprusside (SNP) and isoproterenol, that increase cGMP and cAMP, respectively, also cause dilation that is not blocked by glibenclamide (Fig. [3](#fig03){ref-type="fig"}).

![Effect of arteriole size on dilation to moderate hypercapnia (Paco~2~ \~54 mmHg) and severe hypercapnia (Paco~2~ \~87 mmHg) (see [Table 1](#tbl01){ref-type="table"}). *n* = 8 piglets. \**P* \< 0.05 compared to normocapnia (Paco~2~ \~35 mmHg).](phy2-2-e12127-g1){#fig01}

![The effect of pinacidil and NS1619 on pial arteriolar diameter of newborn pigs before and in the presence of glibenclamide (10^−7^ mol/L). Mean ± SEM,*n* = 8 piglets. \**P* \< 0.05 compared to preceding control.](phy2-2-e12127-g2){#fig02}

![The effect of sodium nitroprusside (SNP) and isoproterenol on pial arteriolar diameter of newborn pigs before and in the presence of glibenclamide (10^−7^ mol/L). Mean ± SEM,*n* = 6 piglets. \**P* \< 0.05 compared to preceding control.](phy2-2-e12127-g3){#fig03}

[Table 1](#tbl01){ref-type="table"} shows blood gases, pH, and mean arterial pressure during ventilation with air, "moderate hypercapnia," and "severe hypercapnia." This elevated Paco~2~ gas is produced by 5 min ventilation with half (moderate hypercapnia) or all (severe hypercapnia) with 10% CO~2~, 20% O~2~, balance nitrogen ([Table 1](#tbl01){ref-type="table"}). [Table 1](#tbl01){ref-type="table"} shows a pure respiratory acidosis. There was a small drop in mean arterial pressure, presumably resulting from massive systemic vasodilation that the newborn heart cannot match.

###### 

Effects of ventilation with elevated Pico~2~ on arterial blood gases, pH, and mean arterial pressure (MAP) of newborn pigs (*n* = 36)

                   Normocapnia   Moderate hypercapnia   Severe hypercapnia
  ---------------- ------------- ---------------------- --------------------
  Pao~2~ (mmHg)    111.7 ± 2.1   103.6 ± 2.2\*          94.6 ± 1.9\*
  Paco~2~ (mmHg)   35.0 ± 0.95   53.9 ± 0.88\*          87.1 ± 1.7\*
  pH~a~            7.46 ± 0.01   7.28 ± 0.06\*          7.09 ± 0.02\*
  MAP (mmHg)       72.0 ± 1.5    72.2 ± 1.8             64 ± 2.2\*

\**P* \< 0.05 compared to normocapnia.

Piglets that were ventilated with air, moderate, and then severe hypercapnia twice had very similar dilations to hypercapnia (Fig. [4](#fig04){ref-type="fig"}, bottom panel). Conversely, cerebrovascular dilation to hypercapnia was inhibited by topical application of glibenclamide (Fig. [4](#fig04){ref-type="fig"}, top).

![The effect of glibenclamide on dilation to moderate hypercapnia (Paco~2~ \~50 mmHg) and severe hypercapnia (Paco~2~ \~70 mmHg). Mean ± SEM,*n* = 6 piglets each, glibenclamide and control. \**P* \< 0.05 compared to normocapnia.](phy2-2-e12127-g4){#fig04}

Ventilation of piglets with 10% CO~2~ increased Paco~2~ to 70--80 mmHg within 5 min and caused a rapid, sustained, and reversible dilation of pial arterioles ([Table 1](#tbl01){ref-type="table"}, Fig. [5](#fig05){ref-type="fig"}). Glibenclamide (10^−7^ mol/L) reduced the dilation to hypercapnia (Fig. [5](#fig05){ref-type="fig"}). Increasing the glibenclamide concentration to 10^−6^ mol/L did not increase the inhibition further (Fig. [6](#fig06){ref-type="fig"}).

![The effect of glibenclamide on dilation to 15‐min hypercapnia (Paco~2~ \~70 mmHg). Mean ± SEM,*n* = 8 piglets. \**P* \< 0.05 compared to previous normocapnia. ^†^*P* \< 0.05 compared to before glibenclamide.](phy2-2-e12127-g5){#fig05}

![The effect of glibenclamide (10^−6^ mol/L) on pial arteriolar dilation to hypercapnia before and after glibenclamide pretreatment. Mean ± SEM,*n* = 6 piglets. \**P* \< 0.05 compared to normocapnia. ^†^*P* \< 0.05 compared to hypercapnia without glibenclamide.](phy2-2-e12127-g6){#fig06}

Topical application of glibenclamide (10^−7^ mol/L) under the cranial window when hypercapnia‐induced dilation is already established caused a constriction of about 35% (Fig. [7](#fig07){ref-type="fig"}). Constriction caused by 10‐fold higher glibenclamide was not markedly increased (Fig. [8](#fig08){ref-type="fig"}).

![Effects of glibenclamide (10^−7^ mol/L) on pial arteriolar diameter beginning 5 min after the onset of hypercapnia. Mean ± SEM,*n* = 14 piglets. \**P* \< 0.05 compared to normocapnia. ^†^*P* \< 0.05 compared to hypercapnia without glibenclamide.](phy2-2-e12127-g7){#fig07}

![Effects of glibenclamide (10^−6^ mol/L) (on pial arteriolar diameter beginning 5 min after the onset of hypercapnia. Mean ± SEM,*n* = 6 piglets. \**P* \< 0.05 compared to normocapnia. ^†^*P* \< 0.05 compared to hypercapnia without glibenclamide.](phy2-2-e12127-g8){#fig08}

From the above, it is clear that glibenclamide -- that blocks dilation to pinacidil completely -- inhibits but does not block dilation to hypercapnia. In search of the signal that causes the rest of the dilation to hypercapnia, we hypothesized that large conductance K~Ca~ channels also contribute to control of newborn cerebral arterioles in response to hypercapnia. Our data suggest that hypercapnia stimulates K~Ca~ channels causing arteriolar hyperpolarization and dilation in addition to the K~ATP~ channels.

Glibenclamide blocks K~ATP~ channels but does not affect dilation to the specific K~Ca~ channel activator NS1619 (Fig. [2](#fig02){ref-type="fig"}). However, the selective K~Ca~ channel blocker paxilline, that does not inhibit dilation to pinacidil, fully blocks cerebral arteriolar dilation to NS1619 (Fig. [9](#fig09){ref-type="fig"}). Also, paxilline attenuates dilation to hypercapnia and paxillin with glibenclamide abolish dilation of newborn pial arterioles in vivo (Fig. [10](#fig10){ref-type="fig"}). Neither the magnitude of the dilatory response to hypercapnia nor these responses to paxillin and glibenclamide are affected by gender (Fig. [10](#fig10){ref-type="fig"}).

![Effects of paxillin on dilation of newborn cerebral arterioles in vivo. Topical paxillin (4 × 10^−5^ mol/L) completely blocked pial arteriolar dilation to the K~Ca~ channel activator, NS1619, top panel (*n* = 5 piglets), but had no effect on dilation to the K~ATP~ channel activator, pinacidil (*n* = 3 piglets). \**P* \< 0.05 compared to the preceding control. ^†^*P* \< 0.05 compared to pinacidil and paxillin.](phy2-2-e12127-g9){#fig09}

![Effects of paxillin (4 × 10^−5^ mol/L) (Pax) alone or in combination with glibenclamide (10^−7^ mol/L) (Glib) on hypercapnia‐induced cerebrovascular dilation in both genders. *n* = 8 piglets.\**P* \< 0.05 compared to the preceding normocapnia. *n* = 8 of each gender.](phy2-2-e12127-g10){#fig10}

Discussion
==========

The findings in this study of newborn pigs include: (1) in the newborn brain, smaller pial arterioles respond more robustly to hypercapnia than do larger pial arterioles; (2) glibenclamide, that effectively and selectively inhibits K~ATP~ channels, reduces but does not completely block dilation to hypercapnia; (3) paxillin, that effectively and selectively inhibits K~Ca~ channels, reduces but does not completely block dilation to hypercapnia; and (4) treatment with both glibenclamide and paxillin completely abolishes hypercapnia‐induced dilation. Overall, these data suggest hypercapnia activates both K~ATP~ and K~Ca~ channels leading to cerebral arteriolar dilation in newborn pigs.

K~ATP~ channels are among a group of interrelated mechanisms potentially determining tone in the cerebral arteries and arterioles (Gollasch et al. [@b7]; Zhuo et al. [@b23]). K~ATP~ channels are constructed of Kir6.0‐type subunits and sulfonylurea receptors and are inhibited by ATP (Zingman et al. [@b24]). These channels are sensitive to sulfonylureas and selective pharmacological channel openers, such as pinacidil (Huang and Chan [@b8]; Zhuo et al. [@b23]).

In the present report, in vivo, we demonstrated selective inhibition of brain surface arteriole K~ATP~ channels by topical application of glibenclamide. Glibenclamide at a dose of 10^−7^ mol/L blocked pial arteriolar dilation to the selective activator of K~ATP~ channels, pinacidil (10^−5^ mol/L) (Fig. [1](#fig01){ref-type="fig"}). Here, we also show that glibenclamide does not affect control pial arteriolar diameter or dilation to NS1619 or isoproterenol (Fig. [2](#fig02){ref-type="fig"}). We show that glibenclamide can partially prevent and partially reverse dilation to hypercapnia. When glibenclamide (10^−7^ mol/L) was injected onto the brain after 5 min of hypercapnia, it caused a 35% decrease in pial arteriolar diameter. Also, when the brain surface was pretreated with glibenclamide prior to the induction of hypercapnia, there was an \~60% decrease in pial arteriolar dilation compared to control without K~ATP~ channel inhibition.

The data in this report show that K~ATP~ channels are among the components that contribute to the dilation of pial arterioles to hypercapnia in newborn pigs. These data clearly demonstrate that glibenclamide inhibits pial arteriolar dilation to hypercapnia rather than totally blocking it. It is unlikely that the incomplete block of dilation to hypercapnia results from too little glibenclamide because 10^−7^ mol/L blocked dilation to pinacidil completely and 10^−6^ mol/L glibenclamide inhibited dilation to hypercapnia to the same degree as did 10^−7^ mol/L glibenclamide.

Our present data show that an additive relationship between K~ATP~ and K~Ca~ channels is sufficient to account for dilations of neonatal pial arterioles in vivo. Others have found that K~ATP~ channels are involved, to various degrees, in dilation of arteries and/or arterioles to hypercapnia (Lindauer et al. [@b15]; Phillis [@b18]; Phillis et al. [@b19]). Our finding that K~ATP~ channel blockade only partially inhibited dilation to hypercapnia in the newborn piglet arouses the question of what is responsible for the rest of the response. Because we showed in piglets that K~ATP~ and K~Ca~ channels are both involved in dilation to H~2~S and H~2~S is involved in dilation to hypercapnia (Leffler et al. [@b12]; Liang et al. [@b13], [@b14]), it was logical to hypothesize that K~Ca~ channels, as well as K~ATP~ channels, may cause dilation of newborn pial arterioles to hypercapnia. We now demonstrate that blockade of both K~ATP~ and K~Ca~ channels abolishes newborn pial arteriolar dilation to hypercapnia, a primary control mechanism of cerebral vascular distribution of blood to match metabolic rate.

In a recent publication (Leffler et al. [@b12]), we found K~ATP~ channels to be among the mechanisms by which H~2~S causes dilation (Leffler et al. [@b12]). We also discovered that inhibition of H~2~S production also inhibited pial arteriolar dilation to hypercapnia. H~2~S increased K~ATP~ channel currents in piglet, freshly isolated, cerebral, arterial, smooth muscle cells (Liang et al. [@b13]). Glibenclamide fully reversed pinacidil‐induced K^+^ currents and partially inhibited H~2~S‐induced K^+^ currents (Liang et al. [@b13]). In isolated, pressurized piglet cerebral arterioles, glibenclamide completely blocked dilation to pinacidil, but only inhibited about half of the dilation to H~2~S (Liang et al. [@b13]), quite similarly to the partial block of hypercapnia‐induced pial arteriolar dilation by glibenclamide observed in the present study. In the case of H~2~S‐induced dilation, much of the K~ATP~ channel‐independent dilation can be attributed to an H~2~S‐induced elevation of sarcoplasmic reticulum K^+^ concentration that increases Ca^2+^ sparks to increase transient K~Ca~ current frequency (Liang et al. [@b14]).

Data in the present report that glibenclamide inhibits dilation of piglet pial arterioles in vivo in response to hypercapnia is in contrast to our earlier report (Leffler et al. [@b11]). In the present study, the efficacy of glibenclamide and the dilation to hypercapnia were measured in the same arterioles. We believe that K~ATP~ channels may not have been effectively inhibited in the earlier paper (Leffler et al. [@b11]).

Brain Paco~2~‐pH is the primary acute regulator of cerebral blood flow. Arteriolar Paco~2~ should have a quicker action than arteriolar pH because movement of ions, H^+^ and , is restricted by the tight junctions of cerebrovascular endothelial cells that make up the blood--brain barrier (BBB). CO~2~ is highly water soluble and lipophilic, readily passing BBB. In fetus and newborn the neurovascular unit and its endothelial cells are particularly vulnerable to conditions injurious to the brain due to rapid proliferation and immature vascular structure. As a result, loss of endothelial function has been demonstrated to occur in the newborn as a consequence of ischemia--reperfusion, cerebral hemorrhage, and seizures. In piglets, seizures cause sufficient cerebral vascular endothelial injury to increase brain‐derived circulating endothelial cells (BCEC) over sevenfold (Parfenova et al. [@b17]). This increase mirrors loss of endothelial‐dependent relaxing factor function including the aforementioned hypercapnic pial artery dilation. Overall, alteration or injury to cerebral vasculature will cause neuronal injury as blood flow distribution does not match metabolism and the blood environment invades the neuropile.

In summary, our new data show there is a major contribution of K~ATP~ and K~Ca~ channels in the dilation of piglet pial arterioles to hypercapnia. This is, however, only part of the mechanism of CO~2~‐related vasodilation and more research is needed to draw conclusions on additional mechanisms.
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